MT-8421

N/A

Report date: 2024/11/04 20:00:50

Base Information

Drug NameMT-8421
Drug Alias NameMT-8421CTLA-4 ETB
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionProtein synthesis inhibitorsT lymphocytes inhibitorsCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsMicrosatellite instability-high cancerMismatch Repair Deficient CancerUterine Cervical Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Templates Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Templates Inc
Active IndicationsN/A
Inactive IndicationsMicrosatellite instability-high cancerMismatch Repair Deficient CancerUterine Cervical Neoplasms +[11] 

Other Information

ATC CodeN/A
Related LinksN/A